> >Register Now <<

Join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: "Research 101: What data can I report from my TMS practice, and how can I report it?"

Speaker: Andrew F. Leuchter, MD

rTMS is a rapidly growing area of clinical practice. Many practitioners have created innovative approaches to treatment, observed novel findings that could help improve outcomes, or discovered new potential indications for rTMS treatment. This presentation will review the types of data that can be reported in the scientific and clinical literature, how to approach creating a report, and how to find the right "home" for publication.

Key learning objectives include:

• Present goals of naturalistic research in TMS practice.
• Discuss different types of research report formats.
• Consider what constitutes a meaningful contribution to the literature.

Take advantage of our live Q&A session at the conclusion of the webinar.

One CME credit is available.  CE Language

*Registered attendees will receive access to the on-demand video recording by Friday, May 9, 2025. You will receive an email notification with instructions on accessing the video. You may register for the on-demand webinar any time after the live webinar.

When:

USA - May 6, 2025 at 8:00pm ET | 5:00pm PT
UK- May 7, 2025 at 1:00am BST
Australia- May 7, 2025 at 10:00am AEST

Cost:

Member: $25
Trainee Member: FREE
Non-Member: $50

All Grand Rounds are recorded and available On-Demand. Recordings are available by the Friday after the live event.

> >Register Now <<

About the Speaker: Andrew F. Leuchter, MD

Andrew F. Leuchter, MD, is a Distinguished Professor of Psychiatry and Director of the Neuromodulation Division at UCLA. An expert on the treatment of mood disorders, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of
the largest academic TMS program in the country and treats patients with depression, OCD, pain, tinnitus, and other neuropsychiatric illness. His research aims to develop novel treatment strategies and predict which treatments are most likely to benefit individual patients.

Dr. Leuchter has authored over 200 scientific articles on topics including neuromodulation for the treatment of depression, EEG biomarkers to guide treatment of neuropsychiatric illness, and theories of antidepressant action. He teaches internationally on TMS and other neuromodulation methods, and received the 2019 Outstanding Research Mentor Award from the Semel Institute.

Andrew F. Leuchter, MD, is a Distinguished Professor of Psychiatry at the Semel Institute for Neuroscience and Human Behavior, and Director of the Neuromodulation Division at the Semel Institute. An expert on the treatment of mood disorders, Dr. Leuchter directs the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. This is one of the largest academic TMS programs, performing clinical treatment and translational research across campuses throughout Los Angeles. The dual mission of the Division is to provide care for patients with depression, chronic pain, OCD, tinnitus, and other difficult-to-treat neuropsychiatric illness, as well as enhancing treatment effectiveness, as well as clinical trials to improve treatment of depression, Post-Traumatic Stress Disorder (PTSD), and Attention-Deficit/Hyperactivity Disorder (ADHD). Dr. Leuchter’s research aims to develop novel treatment strategies and uses brain-imaging techniques, such as quantitative electroencephalography (qEEG) and magnetic resonance imaging (MRI) to examine brain function and predict which treatments are most likely to benefit individual patients.

> >Register Now <<